Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Operating Expenses (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Operating Expenses for 13 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 25.0% to $6.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.2 million, a 1.0% increase, with the full-year FY2025 number at $20.2 million, up 1.0% from a year prior.
  • Operating Expenses was $6.2 million for Q4 2025 at Ekso Bionics Holdings, up from $4.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $7.0 million in Q4 2021 to a low of $4.0 million in Q3 2025.
  • A 5-year average of $5.3 million and a median of $5.2 million in 2024 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: soared 59.87% in 2021, then dropped 23.95% in 2024.
  • Ekso Bionics Holdings' Operating Expenses stood at $7.0 million in 2021, then decreased by 12.24% to $6.1 million in 2022, then fell by 4.84% to $5.8 million in 2023, then decreased by 15.02% to $4.9 million in 2024, then rose by 25.0% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Operating Expenses are $6.2 million (Q4 2025), $4.0 million (Q3 2025), and $4.8 million (Q2 2025).